Outperforming Traditional Staging: A Novel Nomogram for HR-Positive Breast Cancer
This study introduces and validates a novel prognostic nomogram for HR-positive BC, providing enhanced risk stratification, particularly in regions with limited access to comprehensive genetic testing. Further validation through multicenter clinical studies is recommended to confirm its clinical utility.
Authors
- Chaoxing Liu (ORCID: https://orcid.org/0009-0006-8015-6612)
- Chao Shi (ORCID: https://orcid.org/0000-0002-2205-6457)
- Jiabin Ding
- Guohua Zhang (ORCID: https://orcid.org/0000-0001-6091-7492)
- Feng Qiu (ORCID: https://orcid.org/0000-0001-8526-2461)
- Jinbiao Xu
- Chen Fang
Institutions
- Nanchang University (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Therapeutics and Clinical Risk Management
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/tcrm.s485685
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Jiangxi Province